Brian M. Silver, Chief Financial Officer at TScan Therapeutics, Inc. (TCRX), bought 15,000 shares at $3.40 ($51K) on 2022-03-24, disclosed to the SEC on 2022-03-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| TCRX | BUY | 2021-09-13 | $50K | — | Filing → |
| TCRX | BUY | 2021-07-22 | $15K | — | Filing → |